| 000 | 01565 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250514005806.0 | ||
| 264 | 0 | _c20020212 | |
| 008 | 200202s 0 0 rus d | ||
| 022 | _a0040-3660 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aShvetsov, M Iu | |
| 245 | 0 | 0 |
_a[Experience in the use of valsartan with the aim to inhibit progression of kidney failure in patients with chronic glomerulonephritis]. _h[electronic resource] |
| 260 |
_bTerapevticheskii arkhiv _c2001 |
||
| 300 |
_a55-61 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; English Abstract; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntihypertensive Agents _xadministration & dosage |
| 650 | 0 | 4 | _aChronic Disease |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aGlomerulonephritis _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypertension _xcomplications |
| 650 | 0 | 4 |
_aKidney Failure, Chronic _xphysiopathology |
| 650 | 0 | 4 | _aKidney Function Tests |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aProteinuria _xcomplications |
| 650 | 0 | 4 |
_aTetrazoles _xadministration & dosage |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aValine _xadministration & dosage |
| 650 | 0 | 4 | _aValsartan |
| 700 | 1 | _aMedvedeva, T Iu | |
| 700 | 1 | _aKozlovskaia, N L | |
| 700 | 1 | _aMiroshnichenko, N G | |
| 700 | 1 | _aOkonova, E B | |
| 700 | 1 | _aShonichev, D G | |
| 700 | 1 | _aRudenko, T E | |
| 700 | 1 | _aStavrovskaia, E V | |
| 700 | 1 | _aPlieva, O K | |
| 773 | 0 |
_tTerapevticheskii arkhiv _gvol. 73 _gno. 6 _gp. 55-61 |
|
| 999 |
_c11445831 _d11445831 |
||